(-)-catechin has been researched along with gallic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisson, WH; Dashwood, RH; Larsen, CA | 1 |
| Hang, HC; Tsou, LK; Yount, JS | 1 |
2 other study(ies) available for (-)-catechin and gallic acid
| Article | Year |
|---|---|
Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.
Topics: Antineoplastic Agents; Camellia sinensis; Catechin; Cell Line, Tumor; Colonic Neoplasms; Drug Screening Assays, Antitumor; Flavonoids; Gallic Acid; Humans; Kinetics; Models, Molecular; Phenols; Polyphenols; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Receptors, Growth Factor; Structure-Activity Relationship | 2009 |
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
Topics: Bacterial Proteins; Catechin; Dose-Response Relationship, Drug; Epithelial Cells; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Plant Extracts; Salmonella typhimurium; Structure-Activity Relationship; Tea | 2017 |